What is he best known for?
The fields of study he is best known for:
Robert Day spends much of his time researching Furin, Biochemistry, Molecular biology, Proprotein Convertases and Mass spectrometry.
As a part of the same scientific family, he mostly works in the field of Furin, focusing on Virus and, on occasion, Mutant and Cell culture.
His Biochemistry study is mostly concerned with Enzyme, Proteases, Protease, Proprotein convertase and Amino acid.
His Molecular biology study integrates concerns from other disciplines, such as Complementary DNA, Metallocarboxypeptidase D, Dense core granule and In situ hybridization.
His research in Proprotein Convertases intersects with topics in Peptide sequence, In vitro and Proteolytic enzymes.
His Mass spectrometry study combines topics from a wide range of disciplines, such as Proteomics and Ammonium.
His most cited work include:
- Specific MALDI Imaging and Profiling for Biomarker Hunting and Validation: Fragment of the 11S Proteasome Activator Complex, Reg Alpha Fragment, Is a New Potential Ovary Cancer Biomarker (176 citations)
- Substrate Cleavage Analysis of Furin and Related Proprotein Convertases A COMPARATIVE STUDY (114 citations)
- TGFbeta1 regulates gene expression of its own converting enzyme furin. (111 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Biochemistry, Furin, Molecular biology, Proprotein convertase and Proprotein Convertases.
Enzyme, Peptide, Peptide sequence, Structure–activity relationship and Amino acid are the subjects of his Biochemistry studies.
His Furin research is multidisciplinary, incorporating elements of Hemagglutinin, Influenza A virus subtype H5N1, Zymogen and In situ hybridization.
His Molecular biology research focuses on Complementary DNA and how it connects with Carboxypeptidase.
His Proprotein convertase study combines topics in areas such as Gene isoform, Cancer research, Prostate cancer and Cell biology.
His Proprotein Convertases study also includes fields such as
- In vivo which is related to area like In vitro,
- Proteases which intersects with area such as Protease.
He most often published in these fields:
- Biochemistry (30.57%)
- Furin (25.48%)
- Molecular biology (22.29%)
What were the highlights of his more recent work (between 2012-2021)?
- Proprotein convertase (24.84%)
- Peptide (16.56%)
- Biochemistry (30.57%)
In recent papers he was focusing on the following fields of study:
Proprotein convertase, Peptide, Biochemistry, Cancer research and Furin are his primary areas of study.
His studies in Proprotein convertase integrate themes in fields like Molecular biology, Cell biology, Gene knockdown and Gene isoform.
He usually deals with Molecular biology and limits it to topics linked to Computational biology and Microdissection, Tissue sections and Mass spectrometry imaging.
His work deals with themes such as Cell culture, Tandem mass spectrometry, Enzyme, Stereochemistry and In vivo, which intersect with Peptide.
His study in Cancer research is interdisciplinary in nature, drawing from both Cancer, Prostate cancer, Tumor progression, Cell growth and Downregulation and upregulation.
His Furin research includes themes of Endocrinology, Internal medicine and Proprotein Convertases.
Between 2012 and 2021, his most popular works were:
- Development of liquid microjunction extraction strategy for improving protein identification from tissue sections. (63 citations)
- Disruption of the expression of the proprotein convertase PC7 reduces BDNF production and affects learning and memory in mice (57 citations)
- Cleavage of a Neuroinvasive Human Respiratory Virus Spike Glycoprotein by Proprotein Convertases Modulates Neurovirulence and Virus Spread within the Central Nervous System (43 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Molecular biology, Proprotein convertase, Furin, In vivo and Proprotein Convertases.
The concepts of his Molecular biology study are interwoven with issues in Annexin A2, Computational biology, Prostate cancer and Kexin.
Robert Day combines subjects such as HEK 293 cells, Gene Knockdown Techniques and Annexin with his study of Proprotein convertase.
His Furin research is multidisciplinary, relying on both Gene knockout, Internal medicine, Amygdala and Agonist.
Bioinformatics, Furin activity, Infectivity and Shiga toxin is closely connected to Peptidomimetic in his research, which is encompassed under the umbrella topic of In vivo.
His studies deal with areas such as Tumor progression, Cancer, Cancer research and Virology as well as Proprotein Convertases.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
